Efficacy of Individualized Homoeopathic Medicines in the Management of Paediatric Enuresis: A Double-blind, Randomized, Placebo-controlled Trial
试验速览
- 阶段
- 2/3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 159
- 试验地点
- 1
- 主要终点
- DVISS (Dysfunctional Voiding and Incontinence Scoring System)
研究概览
简要总结
Enuresis is a very common problem in childhood. When it persists beyond early childhood, it can be very stressful and distressing to the affected child as well as the family members. It results in severe psychosocial impact and also hampers the normal academic and recreational activities of children. Achieving continence as well as improving quality of life is therefore the main goal of treatment and that will lead to improvement of self-worth and self-confidence. Paediatric enuresis reveals an overall global prevalence ranging from 4 to 16% and prevalence in India is 7.61%–16.3%. Though the use of homoeopathic medicines is prevalent globally to treat the condition, rigorous research evidences in support of homoeopathy in paediatric enuresis has remained compromised. Under such circumstances, we intend to undertake this research project to evaluate the efficacy and safety of homoeopathic medicines in the treatment of enuresis in children. A double-blind Randomized(2:1) placebo-controlled trial will be conducted on 159 paediatric participants with complaints of enuresis. The aim of the trial is to find out the efficacy of IHM in the management of Paediatric enuresis over four months of intervention. The objectives are to detect the group differences in DVISS (Dysfunctional Voiding and Incontinence Scoring System) score (DVISS; primary objective), PEMQOL score, and MYMOP-2 score (secondary objective) between IHM and placebo in the management of paediatric enuresis every month over 4 months of intervention. ITT & PP analysis will be done to detect group differences using tests of unequal variance (e.g., Welch’s t-test) and ANOVA model respectively. The results will be published in scientific journals.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 6.00 Year(s) 至 18.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients suffering from Enuresis (ICD11 6C00) in a frequency of twice and above in a week since last 3 months.
- •Patients scoring 9 or more in DVISS scale in the baseline.
- •Age 6-18 years.
- •Patients of both gender and transgender.
- •Participants having prior experience or knowledge of the treatment.
- •e.g. primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet.
排除标准
- •Not providing written informed consent/ assent forms according to the age of participants as per ICMR guidelines.
- •Patients having any anatomical and/or surgical changes leading to enuresis.
- •Patients who have taken any systemic antibiotics in the past one month.
- •Patients who are too sick for consultation.
- •Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure.
- •Tobacco chewing and /or smoking, alcoholism and/or any form (s) of substance abuse and/or dependence.
- •Self-reported immune-compromised state.
- •Already undergoing homoeopathic treatment for chronic disease within last 6 months.
- •Simultaneous participation in any other clinical trial.
结局指标
主要结局
DVISS (Dysfunctional Voiding and Incontinence Scoring System)
时间窗: Baseline, every month, up to 4 months
次要结局
- Measure Yourself Medical Outcome Profile, version 2.0 (MYMOP-2)(Baseline, every month, up to 4 months)
研究者
Kalyan Chakraborty
D N De Homoeopathic Medical College and Hospital
